Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares FLOT4-AIO: perioperative FLOT versus ECF/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma, Zolbetuximab, CheckMate 649: nivolumab plus chemotherapy as first treatment for advanced gastric, gastro-oesophageal junction and oesophageal adenocarcinoma, FLOT (5-FU, leucovorin, oxaliplatin, docetaxel) and the tag subtype-page.
Shares Salah-Eddin Al-Batran, FLOT4-AIO: perioperative FLOT versus ECF/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma, FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Ramucirumab and the tag subtype-page.
Shares Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2, Zolbetuximab, Ramucirumab, Claudin 18.2 and the tag subtype-page.
Shares Oxaliplatin, Trastuzumab, Trastuzumab deruxtecan, HER2 and the tag subtype-page.
Shares Trastuzumab, Trastuzumab deruxtecan, HER2, Paclitaxel / nab-paclitaxel and the tag subtype-page.
Shares Trastuzumab, Trastuzumab deruxtecan, Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
Shares Trastuzumab deruxtecan, PD-L1, HER2, Paclitaxel / nab-paclitaxel and the tag subtype-page.
Shares Trastuzumab deruxtecan, HER2, Paclitaxel / nab-paclitaxel, Pembrolizumab and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.